JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.58B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1B |
| 3 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$958M |
| 4 |
Eli Lilly
LLY
|
+$776M |
| 5 |
AGN
Allergan plc
AGN
|
+$751M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.98B |
| 3 |
Johnson & Johnson
JNJ
|
+$1.31B |
| 4 |
Merck
MRK
|
+$837M |
| 5 |
Bread Financial
BFH
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.59% |
| 2 | Financials | 15.13% |
| 3 | Healthcare | 11.59% |
| 4 | Technology | 11.09% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CSS
1976
DELISTED
CSS Industries, Inc.
CSS
| $6.3M | ﹤0.01% |
239,247
-5,796
| -2% | -$163K |
2013 Q2
9 quarters
|
|
|
GLF
1977
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $6.29M | ﹤0.01% |
1,029,341
+384,385
| +60% | +$3.27M |
2015 Q1
2 quarters
|
|
|
TGI
1978
DELISTED
Triumph Group
TGI
| $6.28M | ﹤0.01% |
149,157
-52,747
| -26% | -$2.82M |
2013 Q2
9 quarters
|
|
1979
Align Technology
ALGN
$10.3B
| $6.27M | ﹤0.01% |
110,485
-81,060
| -42% | -$4.83M |
2013 Q2
9 quarters
|
|
1980
Tetra Tech
TTEK
$8.63B
| $6.27M | ﹤0.01% |
1,289,730
-257,680
| -17% | -$1.32M |
2013 Q2
9 quarters
|
|
|
RBS.PRS.CL
1981
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $6.27M | ﹤0.01% |
250,448
-359,552
| -59% | -$9.03M |
2013 Q4
7 quarters
|
|
1982
CACI
CACI
$13.9B
| $6.25M | ﹤0.01% |
84,547
-283,853
| -77% | -$22.6M |
2013 Q2
9 quarters
|
|
|
JUNO
1983
DELISTED
Juno Therapeutics, Inc.
JUNO
| $6.24M | ﹤0.01% |
153,395
-301,651
| -66% | -$13.2M |
2014 Q4
3 quarters
|
|
|
CHSP
1984
DELISTED
Chesapeake Lodging Trust
CHSP
| $6.24M | ﹤0.01% |
239,381
+11,281
| +5% | +$341K |
2013 Q2
9 quarters
|
|
1985
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $6.21M | ﹤0.01% |
61,343
+2,310
| +4% | +$275K |
2013 Q2
9 quarters
|
|
|
CRZO
1986
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $6.21M | ﹤0.01% |
203,258
+28,742
| +16% | +$1.04M |
2013 Q2
9 quarters
|
|
1987
Gentex
GNTX
$4.62B
| $6.18M | ﹤0.01% |
398,848
-90,884
| -19% | -$1.44M |
2013 Q2
9 quarters
|
|
1988
State Street SPDR S&P Dividend ETF
SDY
$20.5B
| $6.18M | ﹤0.01% |
85,602
-80,228
| -48% | -$6.04M |
2013 Q2
9 quarters
|
|
|
CA
1989
PUT
DELISTED
CA, Inc.
CA
| $6.16M | ﹤0.01% |
+225,800
| New | +$6.46M |
2015 Q3
0 quarters
|
|
|
PBCT
1990
DELISTED
People's United Financial Inc
PBCT
| $6.13M | ﹤0.01% |
389,279
+124,520
| +47% | +$1.98M |
2013 Q2
9 quarters
|
|
|
SGYP
1991
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $6.12M | ﹤0.01% |
1,155,320
+830,625
| +256% | +$6.43M |
2015 Q2
1 quarter
|
|
|
VA
1992
DELISTED
Virgin America Inc.
VA
| $6.11M | ﹤0.01% |
+178,528
| New | +$5.83M |
2015 Q3
0 quarters
|
|
1993
Larimar Therapeutics
LRMR
$318M
| $6.09M | ﹤0.01% |
15,895
+6,279
| +65% | +$2.83M |
2014 Q3
4 quarters
|
|
1994
Xylem
XYL
$23.6B
| $6.09M | ﹤0.01% |
185,494
-601,637
| -76% | -$20.2M |
2013 Q2
9 quarters
|
|
1995
Cadence Design Systems
CDNS
$96.6B
| $6.08M | ﹤0.01% |
294,212
-153,149
| -34% | -$3.12M |
2013 Q2
9 quarters
|
|
1996
CALL
Eastman Chemical
EMN
$7.32B
| $6.08M | ﹤0.01% |
94,000
| – | – |
2015 Q2
1 quarter
|
|
|
TCF
1997
DELISTED
TCF Financial Corporation Common Stock
TCF
| $6.08M | ﹤0.01% |
187,756
+5,698
| +3% | +$185K |
2013 Q2
9 quarters
|
|
1998
NACCO Industries
NC
$274M
| $6.06M | ﹤0.01% |
557,958
+33,453
| +6% | +$412K |
2013 Q2
9 quarters
|
|
|
FOLD
1999
DELISTED
Amicus Therapeutics
FOLD
| $6.06M | ﹤0.01% |
+433,039
| New | +$6.79M |
2015 Q3
0 quarters
|
|
|
RRMS
2000
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
| $6.03M | ﹤0.01% |
247,678
-45,616
| -16% | -$1.59M |
2015 Q2
1 quarter
|
|
Similar funds
JP Morgan Chase's Q3 2015 Portfolio in Review
As of Q3 2015, JP Morgan Chase held 4,367 positions worth $374B, down 12% from $424B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase withdrew a net $18B in Q3 2015, closing 488 positions and reducing 1,582 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, JP Morgan Chase opened a new position in COLUMBIA PIPELINE GROUP IN COM STK (DE) worth $672M.
- JP Morgan Chase's largest Q3 2015 buy was COLUMBIA PIPELINE GROUP IN COM STK (DE): 36,762,567 shares worth $672M.
- JP Morgan Chase added most to Xtrackers MSCI EAFE Hedged Equity ETF in Q3 2015, an estimated $1.58B increase.
- JP Morgan Chase's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.23B.
- JP Morgan Chase fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $559M.
- JP Morgan Chase's ten largest holdings make up 17% of its $374B portfolio in Q3 2015.
- JP Morgan Chase opened 374 new positions and closed 488 in Q3 2015.
- JP Morgan Chase's portfolio value fell 12% quarter-over-quarter to $374B.
Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.